< Back to companies

Baropharm is a Pharm Tech company based on an integrated pharmaceutical ordering platform under the slogan of “Everything about pharmacy management.” Since its initial service launch in 2021, it has shown rapid growth, achieving sales of over KRW 12 billion in 2023, and has attracted a cumulative investment of over KRW 40 billion from Softbank Asia, Mirae Asset Venture Investment, KB Investment, KDB Industrial Bank, CJ Korea Express, etc. Currently, Baropharm is growing as follows. 1. We identify the inconveniences of pharmacy ordering and operation and provide services that maximize the convenience of ordering medicines at pharmacies. 2. In just three years since its launch, over 20,000 pharmacies (about 80% of the total 25,000 in Korea) are using Baropharm’s integrated pharmaceutical ordering platform. 3. We are expanding into a platform that provides everything about pharmacy management through Baropharm Market, Baropharm Q, etc.

Share
Shareable draft
Get Involved in Baropharm

Company Info

Founded
2019
Website
www.baropharm.com/

Categories

Clinical TrialsPatient RecruitmentData ServicesClinical Research

Technologies

Data ManagementMobile ApplicationsClinical Trial Software
Only accessible to MedStartr community members. Join now

What do you think of Baropharm?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Baropharm
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free